Stephen Barat - Feb 2, 2023 Form 3 Insider Report for HTG MOLECULAR DIAGNOSTICS, INC (HTGMQ)

Role
Senior VP of Therapeutics
Signature
/s/ Shaun D. McMeans, Attorney-in-Fact
Stock symbol
HTGMQ
Transactions as of
Feb 2, 2023
Transactions value $
$0
Form type
3
Date filed
2/10/2023, 03:34 PM
Next filing
Apr 7, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding HTGMQ Common Stock 1.36K Feb 2, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HTGMQ Stock Option (right to buy) Feb 2, 2023 Common Stock 4.17K $62.41 Direct F1
holding HTGMQ Stock Option (right to buy) Feb 2, 2023 Common Stock 2.08K $11.28 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the shares vested on the one-year anniversary of October 1, 2021 (the "Vesting Commencement Date"); the balance of the shares vest in a series of twelve (12) successive equal quarterly installments on the last day of each calendar quarter, commencing with the last day of the calendar quarter first occurring after the one-year anniversary of the Vesting Commencement Date.
F2 The shares vest in a series of eight (8) successive equal quarterly installments on the last day of each calendar quarter, with the first such installment occurring on September 30, 2022.